Showing results (21-30 of 376) with videos related to
Sort By:
Pageof 38
Current Opinion in HIV and AIDS|April 18, 2009
Issues in the design of trials comparing management strategies for heavily pretreated patientsAndrew N Phillips, Cal Cohen, Jens D LundgrenTopics in Antiviral Medicine|January 7, 2025
HIV and Inflamm-Aging: How Do We Reach the Summit of Healthy Aging?Kerry Sheets, Jason V BakerCirculation|December 28, 2022
Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global ContextMpiko Ntsekhe, Jason V BakerCurrent Opinion in HIV and AIDS|October 28, 2010
Biomarkers and HIV-associated cardiovascular diseaseJason V Baker, Daniel DuprezUgeskrift for Laeger|March 7, 2009
[Major breakthroughs in the medical treatment]Ole Kirk, Jan Gerstoft, Jens D Lundgren, et al.Current HIV/AIDS Reports|March 6, 2018
Serious Non-AIDS Conditions in HIV: Benefit of Early ARTJens D Lundgren, Alvaro H Borges, James D NeatonOpen Forum Infectious Diseases|January 9, 2018
Systemic Inflammation, Coagulation, and Clinical Risk in the START TrialJason V Baker, Shweta Sharma, Birgit Grund, et al.Current Opinion in Infectious Diseases|November 22, 2018
Assessing inflammation and its role in comorbidities among persons living with HIVTess E Peterson, Jason V BakerScandinavian Journal of Infectious Diseases|March 6, 2004
Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcomeChristian Ostergaard, Thomas Benfield, Jens D Lundgren, et al.The Journal of Infectious Diseases|December 29, 2022
Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIVCavan S Reilly, Álvaro H Borges, Jason V Baker, et al.Pageof 38